NATCOPHARM - Natco Pharma

Natco Pharma

NATCOPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: V C Nannapaneni · MD: V C Nannapaneni · Listing date: Dec. 27, 1995 · Employees: 5046 · Hyderabad · http://www.natcopharma.co.in

Stock Price vs Company Growth

1.4%

2.9%

10.3%

5.3%

0.3%

38.0%

0.3%

10y

6.3%

all

21.1%

🤔 How to analyze this graph?

Last Traded Price

₹ 906 1.4%

788

950

Company Overview

Sales

4,388 Cr

Growth: 5.7%

Profit after Tax

1,539 Cr

Growth: -9.4%

Mid Cap

16,229 Cr

P/E: 10.5x

Industry P/E: 33.1x

Fundamentals

Sales (Cr)	₹ 4,388
Growth	5.7%
EBITDA	39.6%
P/S	3.7x
Dividend	0.5%
P/E	10.5x
Book Value	₹ 480
PEG Ratio	1.8x
ROE	19.5%
P/B	1.9x

Shareholding Pattern

Institutions

Qualified Institutional Buyers

6.25 %

Mirae Asset Emerging Bluechip Fund

4.06 %

Life Insurance Corporation Of India

2.46 %

Plenty Private Equity Fii I Limited

1.74 %

Nomura Singapore Limited

1.69 %

Promoters

V C Nannapaneni

12.39 %

Time Cap Pharma Labs Limited

9.42 %

Venkata Satya Swathi Kantamani

8.77 %

Natsoft Information Systems Pvt Ltd

8.65 %

Venkaiah Chowdary Nannapaneni Huf

2.98 %

Others

Increase Decrease No change

Company Profile Detailed

Natco Pharma is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). It is also engaged in contract manufacturing business, whereby it undertake selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products. It has diversified into the business of crop health sciences to leverage is skills in organic chemistry.

Belongs to (25 Indices) view more

Investors (172)

marshall...

ndl.infr...

nomura.i...

Followers (39)

nitin2

keerthi

deepak